Arrowstreet Capital
IART icon

Arrowstreet Capital’s Integra LifeSciences IART Stock Holding History

Arrowstreet Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,756
Closed -$312K – 1898
2024
Q4 		$312K Buy
13,756
+913
+7% +$19.9K ﹤0.01% 1617
2024
Q3 		$233K Buy
+12,843
New +$298K ﹤0.01% 1634
2024
Q2 		– Sell
-266,074
Closed -$9.43M – 1642
2024
Q1 		$9.43M Sell
266,074
-193,388
-42% -$7.73M 0.01% 700
2023
Q4 		$20M Sell
459,462
-68,708
-13% -$2.7M 0.02% 420
2023
Q3 		$20.2M Sell
528,170
-53,709
-9% -$2.26M 0.02% 388
2023
Q2 		$23.9M Sell
581,879
-88,084
-13% -$4.24M 0.03% 362
2023
Q1 		$38.5M Sell
669,963
-95
-0% -$5.35K 0.05% 310
2022
Q4 		$37.6M Buy
670,058
+17,677
+3% +$900K 0.05% 284
2022
Q3 		$27.6M Buy
652,381
+137,931
+27% +$7.07M 0.04% 323
2022
Q2 		$27.8M Buy
514,450
+280,004
+119% +$16.8M 0.04% 318
2022
Q1 		$15.1M Buy
234,446
+170,543
+267% +$11.2M 0.02% 456
2021
Q4 		$4.28M Sell
63,903
-118,121
-65% -$7.99M 0.01% 851
2021
Q3 		$12.5M Buy
182,024
+13,360
+8% +$944K 0.02% 664
2021
Q2 		$11.5M Buy
+168,664
New +$11.9M 0.01% 798
2020
Q2 		– Sell
-53,700
Closed -$2.4M – 2370
2020
Q1 		$2.4M Buy
53,700
+42,100
+363% +$2.21M 0.01% 998
2019
Q4 		$676K Buy
+11,600
New +$691K ﹤0.01% 1428
2017
Q2 		– Sell
-154,800
Closed -$6.52M – 1183
2017
Q1 		$6.52M Buy
+154,800
New +$6.61M 0.02% 495
2016
Q4 		– Sell
-348,646
Closed -$14.4M – 2052
2016
Q3 		$14.4M Buy
348,646
+237,668
+214% +$9.96M 0.05% 362
2016
Q2 		$4.43M Buy
+110,978
New +$3.99M 0.01% 616
2016
Q1 		– Sell
-6,000
Closed -$203K – 1418
2015
Q4 		$203K Buy
+6,000
New +$188K ﹤0.01% 1311

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital's IART Position: Q1 2025 in Review

Arrowstreet Capital sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 13,756 shares — an estimated $312K sold.

Arrowstreet Capital first reported a position in IART in Q4 2015 and held it in 20 quarters. The position peaked at $38.5M in Q1 2023. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Arrowstreet Capital reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 13,756 Integra LifeSciences shares in Q1 2025, an estimated $312K.
  • Arrowstreet Capital first reported a position in Integra LifeSciences in Q4 2015 and held it in 20 quarters.
  • Arrowstreet Capital's Integra LifeSciences position peaked at $38.5M in Q1 2023.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Arrowstreet Capital's 13F filing for Q1 2025, filed 14 May 2025.